Journal
JOURNAL OF MICROBIOLOGICAL METHODS
Volume 148, Issue -, Pages 161-168Publisher
ELSEVIER
DOI: 10.1016/j.mimet.2018.04.008
Keywords
Adjuvant antibiotics; Central composite design; Plackett-Burman design; River sediments; Streptazolin; Streptomyces thermoviolaceus
Categories
Funding
- Algerian Ministery of Higher Education and Scientific Research in the frame of the CNEPRU [F00620140028]
Ask authors/readers for more resources
Streptomyces thermoviolaceus SRC3, a newly isolated actinobacterial strain from Algerian river sediments, exhibited a broad activity against various bacterial and yeast human pathogens (Salmonella Typhi ATCC 14028, Vibrio cholerae ATCC 14035, MRSA ATCC 43300 and Candida albicans ATCC 10231). The strain SRC3 was selected from thirty nine actinobacterial isolates and identified as S. thermoviolaceus based on morphology, cultural properties, physiological analyses and 16S rRNA gene sequencing. Culture parameters for the antibiotic production were optimized by sequential statistical strategy including Plackett-Burman design (PBD) and Response Surface Methodology (RSM). In PBD experiments, KCl, K2HPO4, MgSO4 center dot 7H(2)O, pH value and incubation time emerged as the most significant in affecting the output of antimicrobial activities. These factors were further optimized using Central Composite Design (CCD). The best achieved conditions were: KCl (0.01%), K2HPO4 (0.1%), MgSO4 center dot 7H(2)O (0.02%) and 9 days incubation for anti-S. Typhi compounds, KCl (0.051%), MgSO4 center dot 7H(2)O (0.05%) and 5 days incubation for C. albicans inhibitors. The metabolite responsible for the bioactivities was purified, structurally characterized (by NMR, MS, UV and IR analyses) and identified as streptazolin, recently reported as a promising antibiotic adjuvant.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available